Overview
Sweden investment firm's net asset value fell 19.8% in 2025
Company reported SEK -4,676M net income for 2025
Bure Equity acquired 17% stake in Silex Microsystems for SEK 900M
Outlook
Bure expects challenging market conditions to continue into 2026
Company aims to improve profitability and create conditions for future growth
Bure sees high global uncertainty and a strengthening Swedish krona in 2026
Result Drivers
SHARE PRICE DECLINES - Bure's net asset value decline was driven by significant share price drops in Yubico, Xvivo, and Vitrolife, as these companies did not meet growth expectations
MARKET CONDITIONS - Challenging market conditions, including a strong Swedish krona and unmet growth expectations, affected Bure's technology-focused investments
PORTFOLIO ADJUSTMENTS - Bure made strategic investments and divestments, including acquiring a stake in Silex Microsystems and selling shares in Ovzon and Mycronic
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
FY EPS
-SEK 63.20
FY Net Income
-SEK 4.68 bln
FY Net Asset Value
SEK 19.82 bln
Press Release: ID:nMFNbfvWZx
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)